Profit Margin (Annual)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

ADMA Biologics Inc (ADMA) had Profit Margin of 28.80% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$510.17M
Net Income	$146.93M
Cost of Goods Sold	$217.41M
Gross Profit	$292.76M
Operating Expenses	$318.73M
Operating Income	$191.44M
Non-Operating Income/Expense	$-8.79M
Pre-Tax Income	$182.66M
Normalized Pre-Tax Income	$182.66M
Income after Taxes	$146.93M
Income from Continuous Operations	$146.93M
Consolidated Net Income/Loss	$146.93M
Normalized Income after Taxes	$146.93M
EBIT	$191.44M
EBITDA	$200.11M
Weighted-Average Shares Outstanding (Basic)	238.30M
Weighted-Average Shares Outstanding (Diluted)	244.91M
Earnings per Share (EPS) (Basic)	$0.62
Earnings per Share (EPS) (Diluted)	$0.60
Balance Sheet Financials
Current Assets	$466.51M
Property, Plant, and Equipment	$65.06M
Long-Term Assets	$157.73M
Total Assets	$624.24M
Current Liabilities	$69.54M
Long-Term Debt	$75.98M
Long-Term Liabilities	$77.38M
Total Liabilities	$146.92M
Common Equity	$477.32M
Tangible Shareholders Equity	$473.16M
Shareholders Equity	$477.32M
Common Shares Outstanding	237.87M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$50.40M
Cash Flow from Investing Activities	$-21.89M
Cash Flow from Financial Activities	$-44.02M
Beginning Cash	$103.15M
End Cash	$87.63M
Increase/Decrease in Cash	$-15.52M
Stock-Based Compensation	$20.03M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.71
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.14
Debt to Equity Ratio	0.17
Gross Margin	57.39%
Operating Margin	37.53%
EBIT Margin	37.53%
EBITDA Margin	39.22%
Pre-Tax Profit Margin	35.80%
Profit Margin	28.80%
Free Cash Flow	$27.82M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.82
Inventory Turnover	1.05
Receiveable Turnover	3.22
Days Sales in Receivables	113.35
Return on Equity	30.78%
Return on Tangible Equity	31.05%
Return on Assets	23.54%
Return on Investments	26.56%
Book Value Per Share	$2.01
Free Cash Flow per Share	$0.11
Operating Cash Flow per Share	$0.21

Data from Zacks Investment Research, Inc.